These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


149 related items for PubMed ID: 38128610

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Clinical Significance of Microvascular Inflammation in the Absence of Anti-HLA DSA in Kidney Transplantation.
    Parajuli S, Redfield RR, Garg N, Aziz F, Mohamed M, Astor BC, Zhong W, Djamali A, Mandelbrot DA.
    Transplantation; 2019 Jul; 103(7):1468-1476. PubMed ID: 30335696
    [Abstract] [Full Text] [Related]

  • 5. The immunohistochemical expression of von Willebrand factor, T-cadherin, and Caveolin-1 is increased in kidney allograft biopsies with antibody-mediated injury.
    Teixeira AC, Távora F, de Deus E Silva MLF, Prado RMG, de Matos Esmeraldo R, de Sandes-Freitas TV.
    Clin Exp Nephrol; 2021 Mar; 25(3):305-314. PubMed ID: 33242156
    [Abstract] [Full Text] [Related]

  • 6. The clinical and molecular significance of C4d staining patterns in renal allografts.
    Hayde N, Bao Y, Pullman J, Ye B, Calder BR, Chung M, Schwartz D, Alansari A, de Boccardo G, Ling M, Akalin E.
    Transplantation; 2013 Feb 27; 95(4):580-8. PubMed ID: 23274969
    [Abstract] [Full Text] [Related]

  • 7. The relationship of microvascular inflammation with antibody-mediated rejection in kidney transplantation.
    Nankivell BJ, Taverniti A, Viswanathan S, Ronquillo J, Carroll R, Sharma A.
    Am J Transplant; 2024 Jul 30. PubMed ID: 39084463
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Detection of Complement-binding Donor-specific Antibodies, Not IgG-antibody Strength Nor C4d Status, at Antibody-mediated Rejection Diagnosis Is an Independent Predictor of Kidney Graft Failure.
    Malheiro J, Santos S, Tafulo S, Dias L, Martins S, Fonseca I, Almeida M, Pedroso S, Beirão I, Castro-Henriques A, Cabrita A.
    Transplantation; 2018 Nov 30; 102(11):1943-1954. PubMed ID: 29757900
    [Abstract] [Full Text] [Related]

  • 10. Pathology of C4d-negative antibody-mediated rejection in renal allografts.
    Haas M.
    Curr Opin Organ Transplant; 2013 Jun 30; 18(3):319-26. PubMed ID: 23283250
    [Abstract] [Full Text] [Related]

  • 11. Molecular signatures and clinical outcomes of transplant glomerulopathy stratified by microvascular inflammation and donor-specific antibody.
    Lubetzky M, Hayde N, Ó Broin P, Ajaimy M, Bao Y, Mohammed O, Schwartz D, Pullman J, Akalin E.
    Clin Transplant; 2019 Mar 30; 33(3):e13469. PubMed ID: 30578675
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A case of transplant glomerulopathy early after kidney transplantation.
    Shimizu T, Ishida H, Tanabe T, Shirakawa H, Tanabe K, Honda K, Koike J.
    Clin Transplant; 2011 Jul 30; 25 Suppl 23():34-8. PubMed ID: 21623912
    [Abstract] [Full Text] [Related]

  • 14. Clinicopathological analysis of transplant glomerulopathy cases.
    Shimizu T, Ishida H, Shirakawa H, Omoto K, Tsunoyama K, Iida S, Tanabe K, Yamaguchi Y.
    Clin Transplant; 2009 Aug 30; 23 Suppl 20():39-43. PubMed ID: 19594595
    [Abstract] [Full Text] [Related]

  • 15. Significance of C4d Banff scores in early protocol biopsies of kidney transplant recipients with preformed donor-specific antibodies (DSA).
    Loupy A, Hill GS, Suberbielle C, Charron D, Anglicheau D, Zuber J, Timsit MO, Duong JP, Bruneval P, Vernerey D, Empana JP, Jouven X, Nochy D, Legendre CH.
    Am J Transplant; 2011 Jan 30; 11(1):56-65. PubMed ID: 21199348
    [Abstract] [Full Text] [Related]

  • 16. Glomerular C4d Immunoperoxidase in Chronic Antibody-Mediated Rejection and Transplant Glomerulopathy.
    Nankivell BJ, P'Ng CH, Shingde M.
    Kidney Int Rep; 2022 Jul 30; 7(7):1594-1607. PubMed ID: 35812271
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Molecular diagnosis of antibody-mediated rejection: Evaluating biopsy-based transcript diagnostics in the presence of donor-specific antibodies but without microvascular inflammation, a single-center descriptive analysis.
    Harmacek D, Weidmann L, Castrezana Lopez K, Schmid N, Korach R, Bortel N, von Moos S, Rho E, Helmchen B, Gaspert A, Schachtner T.
    Am J Transplant; 2024 Sep 30; 24(9):1652-1663. PubMed ID: 38548057
    [Abstract] [Full Text] [Related]

  • 20. Circulating donor-specific anti-HLA antibodies are a major factor in premature and accelerated allograft fibrosis.
    Gosset C, Viglietti D, Rabant M, Vérine J, Aubert O, Glotz D, Legendre C, Taupin JL, Duong Van-Huyen JP, Loupy A, Lefaucheur C.
    Kidney Int; 2017 Sep 30; 92(3):729-742. PubMed ID: 28554738
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.